The impact of RAGE inhibition in animal models of bacterial sepsis: A systematic review and meta-analysis

Journal of International Medical Research

Volumn 46, Issue 1, 2018, Pages 11-21

  Zhao, Xin ^a   Liao, Yan Nian ^a   Huang, Qian ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Meta analysis; Receptor for advanced glycation end products; Sepsis; Systematic review

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; AGER PROTEIN, MOUSE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFLAMMATORY CELL; KLEBSIELLA PNEUMONIAE; LUNG INJURY; META ANALYSIS; NONHUMAN; QUALITY CONTROL; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; MOUSE; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, KNOCKOUT; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; SEPSIS;

EID: 85041411125     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060517713856     Document Type: Article

References (24)

1. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 2013; 93: 1247–1288. doi: 10.1152/physrev.00037.2012.
2. Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45: 486–552. doi: 10.1097/CCM.0000000000002255.
3. Kierdorf K and Fritz G. RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol 2013; 94: 55–68. doi: 10.1189/jlb.1012519.
4. Creagh-Brown BC, Quinlan GJ, Evans TW, et al. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target? Intensive Care Med 2010; 36: 1644–1656. doi: 10.1007/s00134-010-1952-z.
5. Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 2005; 83: 876–886.
6. Christaki E, Lazaridis N and Opal SM. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis? Curr Opin Infect Dis 2012; 25: 304–311. doi: 10.1097/QCO.0b013e3283519b82.
7. Macleod MR, O’Collins T, Howells DW, et al. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004; 35: 1203–1208.
8. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 1–16.
9. Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004; 113: 1641–1650.
10. Lutterloh EC, Opal SM, Pittman DD, et al. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care 2007; 11: R122.
11. van Zoelen MA, Schouten M, de Vos AF, et al. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009; 182: 4349–4356. doi: 10.4049/jimmunol.0801199.
12. van Zoelen MA, Schmidt AM, Florquin S, et al. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J Infect Dis 2009; 200: 765–773. doi: 10.1086/604730.
13. Ramsgaard L, Englert JM, Manni ML, et al. Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One 2011; 6: e20132. doi: 10.1371/journal.pone.0020132.
14. Tadie´ JM, Bae HB, Banerjee S, et al. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing. Am J Physiol Cell Physiol 2012; 302: C249–C256. doi: 10.1152/ajpcell.00302.2011.
15. Achouiti A, de Vos AF, de Beer R, et al. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia. J Innate Immun 2013; 5: 603–612. doi: 10.1159/000348739.
16. Achouiti A, van der Meer AJ, Florquin S, et al. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia. Crit Care 2013; 17: R296. doi: 10.1186/cc13162.
17. Achouiti A, Van’t Veer C, de Vos AF, et al. The receptor for advanced glycation end products promotes bacterial growth at distant body sites in Staphylococcus aureus skin infection. Microbes Infect 2015; 17: 622–627. doi: 10.1016/j.micinf.2015.06.002.
18. Achouiti A, de Vos AF, van’t Veer C, et al. Receptor for Advanced Glycation End Products (RAGE) serves a protective role during Klebsiella pneumoniae - induced pneumonia. PLoS One 2016; 11: e0141000. doi: 10.1371/journal.pone.0141000.
19. Noto MJ, Becker KW, Boyd KL, et al. RAGE-mediated suppression of Interleukin-10 results in enhanced mortality in a murine model of Acinetobacter baumannii sepsis. Infect Immun 2017; 85: e00954–1016. doi: 10.1128/IAI.00954-16.
20. van Zoelen MA, Achouiti A and van der Poll T. The role of receptor for advanced glycation endproducts (RAGE) in infection. Crit Care 2011; 15: 208. doi: 10.1186/cc9990.
21. Buras JA, Holzmann B and Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005; 4: 854–865.
22. Laszlo I, Trasy D, Molnar Z, et al. Sepsis: From Pathophysiology to Individualized Patient Care. J Immunol Res 2015; 2015: 510436. doi: 10.1155/2015/510436.
23. van Zoelen MA, Achouiti A and van der Poll T. RAGE during infectious diseases. Front Biosci (Schol Ed) 2011; 3: 1119–1132.
24. Jeong SJ, Lim BJ, Park S, et al. The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model. Inflamm Res 2012; 61: 1211–1218. doi: 10.1007/s00011-012-0518-7.